RENFRO LARRY C 4

4 · UNITEDHEALTH GROUP INC · Filed Feb 14, 2018

Form 4

Period: 2018-02-12

EVP, UHG & CEO, Ovations

Transactions

Tax Payment
Common Stock
2018-02-12$225.69/sh−1,797$405,565→ 166,632.63 total
Award
Common Stock
2018-02-13+35,130→ 201,762.63 total
Tax Payment
Common Stock
2018-02-13$226.64/sh−15,616$3,539,210→ 186,146.63 total
Award
Common Stock
2018-02-13+9,266→ 195,412.63 total
Award
Non-Qualified Stock Options (right to buy)
2018-02-13+49,505→ 49,505 total
Exercise: $226.64Exp: 2028-02-13→ Common Stock (49,505 underlying)

Footnotes (5)

[F1]Represents the settlement of Performance Share Awards for the performance period 2015-2017.
[F2]Represents the withholding of shares to satisfy tax obligations upon the settlement of Performance Share Awards for the performance period 2015-2017.
[F3]The restricted stock units vest at a rate of 25% annually on February 13 from the years 2019 through 2022.
[F4]Amount does not include Performance Share Awards granted to the executive officer on February 13, 2018, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of Performance Shares that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of Performance Shares is 18,532.
[F5]The stock options vest at a rate of 25% annually on February 13 from the years 2019 through 2022.

Documents

1 file